Table 2 Adherence and clinical outcome measures at visit nearest to 180 days after initiation or at second CD4 test in subgroup with test in months 4 to 9.
| Â | Total (n = 488) | With CD4 test (n = 409) |
|---|---|---|
Average number of days since treatment initiation (min, max) | 178 (124,337) | 188 (98,270) |
Dispensing-based adherence | Â | Â |
% of days covered since ART start | Â | Â |
   < 80% | 2.9% | 2.4% |
   80% to <85% | 2.7 | 2.0 |
   85% to <90% | 2.9 | 3.9 |
   90% to <95% | 8.0 | 8.1 |
   95% to <100% | 20.1 | 19.6 |
   100% | 63.5 | 64.1 |
% with gap in treatment >30 days | 2.7% | 3.4% |
Self-report adherence | Â | Â |
Average (s.d.) number of self-reports recorded in medical record during follow-up | 5.7 (1.8) | 5.4 (2.0) |
Average (s.d.) of all self-reports * | 1.17 (0.39) | 1.16 (0.33) |
% all self-reports perfect * | 72.6% | 74.4% |
% any self-report poor * | 3.0% | 2.9% |
Appointment keeping | Â | Â |
Average number (s.d.) of visits | 6.4 (1.1) | 6.0 (1.6) |
% visits on/before scheduled day | Â | Â |
   < 80% | 19.9% | 18.1% |
   80% to <90% | 22.1 | 20.5 |
   90% to 100% | 58.1 | 61.4 |
% visits ≤ 3 days after scheduled |  |  |
   < 80% | 5.9% | 5.7% |
   80% to <90% | 13.1 | 11.1 |
   90% to 100% | 81.0 | 83.2 |
Dispensing-based appointment keeping | Â | Â |
% of visits before finishing ARVs dispensed during previous visit | Â | Â |
   < 80% | 44.9% | 44.0% |
   80% to <90% | 27.5% | 27.1 |
   90% to 100% | 27.7% | 28.9 |
Change in clinical outcome measures | Â | Â |
Average (s.d.) increase in CD4 count | NA | 138.1 (125.5) |
Average (s.d.) weight gain (kg) | 3.9 (5.1) | 3.8 (4.8) |